Testing effectiveness (Phase 2)WithdrawnNCT01649388
What this trial is testing
A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients
Who this might be right for
Kidney Transplantation
Talaris Therapeutics Inc.